Showing results (121-130 of 6,383) with videos related to

Sort By:
Pageof 639
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2015
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CTTheodosia Maina, Hendrik Bergsma, Harshad R Kulkarni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2015
Selective internal radiation therapy in patients with progressive neuroendocrine liver metastasesCharlotte Ebeling Barbier, Ulrike Garske-Román, Mattias Sandström, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 29, 2015
Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysisElizabeth Morris, Anastasia Chalkidou, Alexander Hammers, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 29, 2015
Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairmentEun Hyun Seo, I L Han Choo,
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Pilot prospective evaluation of (18)F-FPPRGD2 PET/CT in patients with cervical and ovarian cancerRyogo Minamimoto, Amer Karam, Mehran Jamali, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PETAnnarita Ianniello, Maddalena Sansovini, Stefano Severi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 16, 2015
Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trialAlain Manrique, Patricia Lemarchand, Béatrice Delasalle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 25, 2022
Usefulness of 18F-FPP-RGD2 PET in pathophysiological evaluation of lung fibrosis using a bleomycin-induced rat modelShuichi Hiroyama, Keiko Matsunaga, Miwa Ito, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 1, 2017
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation studyMichela Del Prete, François-Alexandre Buteau, Jean-Mathieu Beauregard
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2019
Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trialT Konert, W V Vogel, D Paez, et al.
Pageof 639